Pinsent Masons advised NanoTemper Technologies GmbH in its recent acquisition of SAW Instruments GmbH (Bonn, Germany).
By acquiring SAW Instruments and their proprietary Surface Acoustic Wave technology, NanoTemper expands its portfolio by an additional methodology for biomolecular interaction analysis.
The Pinsent Masons team was led by corporate partner, Tobias Rodehau, aligned by Dr. Florian Anselm, Legal Director, Olivia Irrgang and Marina Arntzen.

NanoTemper Technologies GmbH
NanoTemper Technologies, founded in 2008, is a globally operating high-tech company that develops, produces and markets instruments for biomolecular analytics. NanoTemper's proprietary technology MicroScale Thermophoresis (MST) allows identifying and developing drug candidates and enables customers to test the drugs' potency quickly and effectively.